🇺🇸 FDA
Pipeline program

Huperzine A, Huperzine A, Capsules, Huperzine A

817P203

Phase 2 small_molecule active

Quick answer

Huperzine A, Huperzine A, Capsules, Huperzine A for Focal Onset Seizures is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Focal Onset Seizures
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials